MetaCap

Aardvark Therapeutics (AARD) vs Cocrystal Pharma (COCP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cocrystal Pharma (COCP) has outperformed Aardvark Therapeutics (AARD) over the past year, gaining 5.6% versus a loss of 90.2%. Aardvark Therapeutics is the larger company by market cap ($20.2 million vs $18.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AARD-90.15%COCP+5.56%
+83%-8%-99%
Nov 21, 20251 yearNov 20, 2026
AARD-93.06%COCP-48.65%
+28%-35%-99%
Feb 10, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AARD versus COCP key metrics
MetricAARDCOCP
Share price$0.9226$0.95
Market cap$20.20M$18.30M
1-day change-7.74%-2.05%
YTD return-92.97%-3.06%
1-year return-90.15%+5.56%
5-year return—-91.84%
EPS (TTM)$-3.33$-0.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$0—
Net income (latest FY)$-57.59M$-8.83M
52-week high$16.60$2.03
52-week low$0.90$0.76
Distance from 52-week high-94.44%-53.20%
Analyst consensusbuynone
Avg. price target upside+1104.21%+847.37%
Average volume643.53K40.65K
Shares outstanding21.89M19.26M
Employees2810
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • COCP has outperformed AARD by 95.7 percentage points over the past year.

About Aardvark Therapeutics

AARD stock →

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc.

Health Care · Biotechnology: Pharmaceutical Preparations · 28 employees

About Cocrystal Pharma

COCP stock →

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.

Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees

AARD vs COCP FAQ

Which is bigger, Aardvark Therapeutics or Cocrystal Pharma?

Aardvark Therapeutics (AARD) is larger, with a market capitalization of $20.20M compared with $18.30M for Cocrystal Pharma (COCP).

Which stock has performed better over the past year, AARD or COCP?

COCP returned +5.56% over the past 12 months, compared with -90.15% for AARD (price return, excluding dividends). Past performance does not predict future results.

Are Aardvark Therapeutics and Cocrystal Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons